Study participants were randomly assigned to receive either oral vepdegestrant (n=313) or intramuscular fulvestrant (n=311). The primary endpoint was progression free survival (PFS) among all patients ...

Lower odds of relapse seen among Medicare beneficiaries in prescription drug plans, Medicare Advantage Prescription Drug plans.

Move follows RFK Jr.'s abrupt dismissal of the entire ACIP in June, alleging it was too aligned with manufacturers ...

China doesn't have access to those vaccines. Instead, health officials there are using other methods to slow the outbreak, such as using drones to spray mosquito repellent and releasing fish into ...

Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

The use of products contaminated with B. cepecia may result in local infections and possibly more serious infections in immunocompromised individuals.

Sustained benefits seen in overall survival, progression-free survival, objective response rate with combo vs sunitinib.

Significant increase seen in crude nitrous oxide poisoning rate from 2010 to 2018, but no increase seen from 2019 to 2023.

HealthDay News — Electronic cigarette (e-cigarette) flavor restriction policies are associated with reductions in e-cigarette use, according to a study published online July 30 in JAMA Network Open.

As part of a postmarketing requirement, Valneva will be initiating a study to assess the risk of severe chikungunya-like adverse reactions following administration of Ixchiq.

Findings from key secondary endpoints showed 59.6% of patients taking orforglipron 36mg (highest dose) achieved a reduction in body weight of 10% or greater vs 8.6% of patients receiving placebo; ...

The randomized, double-blind, CONVOKE trial evaluated the safety and efficacy of CT-155, a PDT that provides interactive psychosocial intervention techniques via a smartphone app.